Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  DexCom, Inc.    DXCM

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/17/2017 07/18/2017 07/19/2017 07/20/2017 07/21/2017 Date
70.69(c) 69.97(c) 70(c) 70.01(c) 69.52(c) Last
1 992 186 761 190 1 158 311 642 160 510 888 Volume
-1.44% -1.02% +0.04% +0.01% -0.70% Change
More quotes
Financials ($)
Sales 2017 726 M
EBIT 2017 -57,4 M
Net income 2017 -60,5 M
Finance 2017 131 M
Yield 2017 -
Sales 2018 954 M
EBIT 2018 8,01 M
Net income 2018 2,73 M
Finance 2018 191 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018 1 488,65
EV / Sales2017 8,09x
EV / Sales2018 6,10x
Capitalization 6 003 M
More Financials
Company
DexCom, Inc. is a medical device manufacturing company, which engages in the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes.Its products include Dexcom G4 PLATINUM System, Dexcom studio and Mobile apps.The company was... 
More about the company
Surperformance© ratings of DexCom, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on DEXCOM, INC.
07/07 DEXCOM : Announces Upcoming Conference Presentation
06/22 DEXCOM : New Study Shows Adults with Type 1 and Type 2 Diabetes on Multiple Dail..
06/20 DEXCOM SCHEDULES SECOND QUARTER 2017 : 30 p.m. Eastern Time
06/15 DEXCOM : to Add Ambulatory Glucose Profile AGP to Dexcom CLARITY®
06/12 DEXCOM INC : Other Events (form 8-K)
06/09 DEXCOM : New Study Shows Adults with Type 1 and Type 2 Diabetes on Multiple Dail..
06/09 DEXCOM : New Study Shows Adults with Type 1 and Type 2 Diabetes on Multiple Dail..
06/08 DEXCOM : to Add Ambulatory Glucose Profile (AGP) to Dexcom CLARITY®
06/07 DEXCOM : Announces FDA Approval of G5 Mobile App for Android Devices
06/06 DEXCOM INC : Change in Directors or Principal Officers, Amendments to Articles o..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
07/20 Abbott profit forecast gets a lift from St. Jude integration
07/13 BURBERRY : Nearly a third of Burberry investors object to top executives' pay
07/11DJZIMMER BIOMET : Announces Leadership Transition
05/23DJFirms Persuade SEC on Profit Metric -- WSJ
05/22DJCompanies Are Winning the Battle Over Adjusted Earnings
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
07/21#SwingTradeAlert Recent $DXCM technical alerts: NR7 plus 8 more alerts...  
07/18DexCom upgraded by Zacks Investment Research to hold.  
07/18DexCom, Inc. $DXCM Rating Reiterated by Cowen and Company  
07/17#SwingTradeAlert Recent $DXCM technical alerts: 50 DMA Resistance plus 2 more.. 
07/15DexCom's buy rating reiterated at Cowen and Company. $90.00 PT.  
More tweets
Qtime:24
News from SeekingAlpha
07/05 The Future Of Dexcom
07/03 Lean Long-Term Growth Portfolio - Midyear 2017 Update
06/09 WEAR ETF (WEAR) May Summary
06/06 VAREX : An Overlooked Spin-Off With 25% Upside
06/05 DexCom shares up over 4% on Apple glucose data inclusion
Chart DEXCOM, INC.
Duration : Period :
DexCom, Inc. Technical Analysis Chart | DXCM | US2521311074 | 4-Traders
Technical analysis trends DEXCOM, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 90,0 $
Spread / Average Target 29%
EPS Revisions
Managers
NameTitle
Kevin Ronald Sayer President, Chief Executive Officer & Director
Terrance H. Gregg Executive Chairman
Jeffrey C. Moy Senior Vice President-Operations
Kevin Sun Chief Financial Officer & Vice President
Jacob Leach Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
DEXCOM, INC.16.45%6 003
MEDTRONIC PLC19.57%115 748
BAXTER INTERNATIONAL41.34%34 072
ZIMMER BIOMET HOLDINGS INC25.59%26 135
C R BARD INC43.43%23 334
HOYA CORPORATION18.31%20 410